Article
The impact of the availability of prevention studies on the desire to undergo predictive testing in persons at risk for autosomal dominant Alzheimer's disease.
Contemporary clinical trials - 1 Sept 2013
Hooper Megan, Grill Joshua D, Rodriguez-Agudelo Yaneth, Medina Luis D, Fox Michelle, Alvarez-Retuerto Ana Isabel, Wharton David, Brook Jenny, Ringman John M
Abstract excerpt
Persons at risk for autosomal dominant neurodegenerative diseases provide the opportunity to efficiently test preventive interventions. Only a minority of such persons, however, choose to undergo revealing genetic testing, presenting a challenge to enrollment. Thirty-four preclinical Latinos (n = 26) and non-Latinos at risk for familial Alzheimer's disease (FAD) unaware of their genetic status were administered a...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
